Clinical Trials Logo

Clinical Trial Summary

The aim of the current study is to compare lateral bone augmentation using the current gold standard (FDBA plus resorbable collagen membrane) versus Ossix Volumax as a stand-alone material.


Clinical Trial Description

One of the major problems in implant therapy is the need to regenerate bone after its resorption because of periodontal disease, traumatic extraction or surgical removal associated with treatment of invasive lesions.

Ossix Volumax is a novel volume maintaining collagen scaffold designed for bone augmentation in the atrophic ridge. It is 1-2 mm in thickness and undergoes mineralization progressing into ossification.

Thirty subjects requiring lateral bone augmentation of the maxilla or the mandible will be recruited study: Of these, twenty will be recruited and treated at the School of Dental Medicine, Harvard University, Boston, USA and ten (10) at the School of Graduate Dentistry, Rambam health care campus, Haifa, Israel.

Hypothesis:

The use of Ossix Volumax as a stand-alone augmentation material will results similar increase in the ridge width and volume compared to FDBA and barrier membrane when coupled together. ;


Study Design


Related Conditions & MeSH terms

  • Alveolar Ridge Augmentation, Dental Implants

NCT number NCT03457298
Study type Interventional
Source Rambam Health Care Campus
Contact Eli Machtei, DMD
Phone 9727772983
Email machtei@rambam.health.gov.il
Status Recruiting
Phase N/A
Start date November 7, 2018
Completion date July 2020